Business registries · firm from USPTO records
RXi Pharmaceuticals Corporation
USPTO only Derived from USPTO records only (patent assignees and trademark owners); FURP found no state registration, Form D, Form ADV, nonprofit, SEC or lobbying record with this name and place.
- Place
- 60 Prescott Street, Worcester, MA
- Entity type
- Corporation
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 16 granted 2008-03-10 to 2019-01-01
- Trademarks
- 17, 1 live
- Record
- EXACT high confidence: USPTO records only: patent assignee and trademark owner with the same name (legal endings aside) and place
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 10167471 | Inhibition of PCSK9 through RNAI | 2019-01-01 | PVGPATDIS, file of 2026-04-10 |
| US 10138485 | Neutral nanotransporters | 2018-11-27 | PVGPATDIS, file of 2026-04-10 |
| US 10131904 | Modified RNAi polynucleotides and uses thereof | 2018-11-20 | PVGPATDIS, file of 2026-04-10 |
| US 10041073 | Reduced size self-delivering RNAi compounds | 2018-08-07 | PVGPATDIS, file of 2026-04-10 |
| US 9963702 | RNA interference in dermal and fibrotic indications | 2018-05-08 | PVGPATDIS, file of 2026-04-10 |
| US 9938530 | RNA interference in skin indications | 2018-04-10 | PVGPATDIS, file of 2026-04-10 |
| US 9745574 | RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality | 2017-08-29 | PVGPATDIS, file of 2026-04-10 |
| US 9493774 | Inhibition of PCSK9 through RNAi | 2016-11-15 | PVGPATDIS, file of 2026-04-10 |
| US 9340786 | RNA interference in dermal and fibrotic indications | 2016-05-17 | PVGPATDIS, file of 2026-04-10 |
| US 9303259 | RNA interference in skin indications | 2016-04-05 | PVGPATDIS, file of 2026-04-10 |
| US 9175289 | Reduced size self-delivering RNAi compounds | 2015-11-03 | PVGPATDIS, file of 2026-04-10 |
| US 9095504 | RNA interference in ocular indications | 2015-08-04 | PVGPATDIS, file of 2026-04-10 |
| US 9080171 | Reduced size self-delivering RNAi compounds | 2015-07-14 | PVGPATDIS, file of 2026-04-10 |
| US 9074211 | Inhibition of MAP4K4 through RNAI | 2015-07-07 | PVGPATDIS, file of 2026-04-10 |
| US 8815818 | Phagocytic cell delivery of RNAI | 2014-08-26 | PVGPATDIS, file of 2026-04-10 |
| US 8796443 | Reduced size self-delivering RNAi compounds | 2014-08-05 | PVGPATDIS, file of 2026-04-10 |
| US 8664189 | RNA interference in skin indications | 2014-03-04 | PVGPATDIS, file of 2026-04-10 |
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| PHIO PHARMACEUTICALS | 88170269 | 2018-10-26 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| SAMCYPRONE | 86476105 | 2014-12-10 | Registration cancelled | 005 | TRTYRAP, file of 2026-04-03 |
| RXRNAORI | 85223073 | 2011-01-21 | Registration cancelled | 001 | TRCFECO2, file of 2024-03-27 |
| SD-RXRNA | 85223055 | 2011-01-21 | Registration cancelled | 001 | TRCFECO2, file of 2024-03-27 |
| RXRNA | 85223046 | 2011-01-21 | Registration cancelled | 001 | TRCFECO2, file of 2024-03-27 |
| NEXT GENERATION IN RNAI | 85223031 | 2011-01-21 | Registration cancelled | 001 | TRCFECO2, file of 2024-03-27 |
| RXI | 85223019 | 2011-01-21 | Registration cancelled | 001 | TRCFECO2, file of 2024-03-27 |
| RXI | 85223006 | 2011-01-21 | Registration cancelled | 001 | TRCFECO2, file of 2024-03-27 |
| RXRNA NANO | 77871877 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| RXRNA SOLO | 77871873 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| RXRNA ORI | 77871870 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| SD-RXRNA | 77871869 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| RXRNA | 77871864 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| NEXT GENERATION IN RNAI | 77871861 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| RXI | 77871850 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| RXI | 77871831 | 2009-11-13 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| RXRNA | 77417773 | 2008-03-10 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
Possible related entities
- Advanced Body Sensing, LLC firm from USPTO records, 2 trademarks FUZZY same street address (trademark filings)
- Blue Sky Biotech, Inc. firm from USPTO records, 1 trademarks FUZZY same street address (trademark filings)
- RNCS, INC. firm from USPTO records, 12 trademarks FUZZY same street address (trademark filings)
Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.